Consensus Cloud Solutions Earnings Call Transcripts
Fiscal Year 2026
-
Q3 revenue rose 3.7% YoY, with corporate growth, adjusted EBITDA and adjusted EPS advancing; FY26 adjusted EPS guidance increased. Strong retention and VA expansion offset SoHo decline, while slower customer decisions remain a headwind.
-
Q2 2026 saw strong revenue and margin growth, led by a 9.3% year-over-year increase in the corporate channel and robust free cash flow. Strategic moves included a new healthcare group and the doc.health acquisition. Guidance was reaffirmed, with expectations to finish above the midpoint.
-
A quorum was established and all four proposals, including director elections and auditor ratification, were approved. No questions were submitted by stockholders, and final voting results will be filed with the SEC.
-
Q1 2026 saw 1.5% consolidated revenue growth, with corporate channel revenue up 8.2% year-over-year and strong free cash flow supporting share repurchases. Full-year guidance was reaffirmed, and new AI-driven product launches are expected to drive future growth.
Fiscal Year 2025
-
Record 2025 results with strong corporate channel growth, stable margins, and record free cash flow. 2026 guidance projects continued revenue growth, robust free cash flow, and increased share repurchases, with AI-driven solutions and public sector wins fueling future expansion.
-
Q3 2025 delivered record corporate revenue, strong free cash flow, and robust VA growth, while SOHO revenue declined as planned. Debt was reduced and capital allocation remains opportunistic, with Q4 guidance reflecting seasonal margin pressure and continued investment.
-
Q2 saw a return to consolidated revenue growth, led by a 6.9% year-over-year increase in the corporate segment and robust free cash flow. Full-year guidance for revenue and EBITDA was reaffirmed, with adjusted EPS guidance raised. Demand in healthcare remains strong despite industry headwinds.
-
Corporate revenue grew 5.6% year-over-year, driving record retention and customer growth, while adjusted EBITDA margin exceeded expectations. Soho revenue decline slowed, and guidance for 2025 was reaffirmed, with no current impact from tariffs or macroeconomic volatility.
Fiscal Year 2024
-
Q4 and full year 2024 results exceeded expectations, with strong corporate growth and improved margins, while SoHo declines slowed. 2025 guidance projects flat total revenue, with corporate growth offsetting further SoHo declines, and continued investment in go-to-market and AI solutions.
-
Q3 2024 results exceeded expectations for revenue and profitability, with strong corporate growth and effective cost management driving a 53.5% EBITDA margin. Debt reduction and robust free cash flow continued, while guidance for Q4 and full year 2024 was narrowed within prior ranges.
-
Q2 2024 saw strong performance in revenue, profitability, and cash flow, driven by cost optimization and growth in the corporate channel, especially healthcare. The VA rollout is progressing, with multi-year growth expected, while SoHo revenue decline is slowing due to optimized marketing. Guidance for full-year revenue and EBITDA is reaffirmed, with EPS guidance raised.
-
The company is expanding from its core eFax service into advanced healthcare solutions, driving most new revenue from the healthcare sector. While SoHo revenue is managed for decline, corporate growth and strong cash flow support debt reduction and future expansion, with reaffirmed 2024 guidance.
-
The company is expanding its healthcare-focused digital information exchange solutions, with AI-driven products and a flexible platform for interoperability. Financially, it is shifting SOHO strategy to improve margins, growing corporate revenue, and prioritizing debt reduction and share repurchases.